` BRAINP (Brain+ A/S) vs OMX Copenhagen 25 Comparison - Alpha Spread

B
BRAINP
vs
O
OMX Copenhagen 25

Over the past 12 months, BRAINP has underperformed OMX Copenhagen 25, delivering a return of -90% compared to the OMX Copenhagen 25's 2% drop.

Stocks Performance
BRAINP vs OMX Copenhagen 25

Loading
BRAINP
OMX Copenhagen 25
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BRAINP vs OMX Copenhagen 25

Performance Gap Between BRAINP and OMXC25
HIDDEN
Show

Performance By Year
BRAINP vs OMX Copenhagen 25

Loading
BRAINP
OMX Copenhagen 25
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Brain+ A/S vs Peers

OMX Copenhagen 25
BRAINP
VEEV
PME
2413
DOCS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Brain+ A/S
Glance View

Market Cap
10.9m DKK
Industry
Health Care

Brain+ A/S is engaged in the developing of medical software to detect and treat the cognitive symptoms of dementia and the most common cause of dementia, namely Alzheimer's disease. The firm focuses on the development of digital treatment for dementia and Alzheimer’s disease by digital therapeutics. The Company’s main activities include the development of Cognitive Stimulation Therapy for the treatment of dementia, Computerized Cognitive Training for the treatment of earlier stages of Alzheimer’s and Starry Night memory test for early detection and monitoring of Alzheimer’s. The company offers a product called Digital CST assistant giving access to Cognitive Stimulation Therapy sessions, available in Danish.

BRAINP Intrinsic Value
HIDDEN
Show
Back to Top